Ameritas Investment Partners’s IGM Biosciences IGMS Stock Holding History

Ameritas Investment Partners’s Portfolio IGMS Stock Details IGMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,327	Closed	-$1.53K	–	3261
2025 Q1	$1.53K	Hold	1,327	–	–	﹤0.01%	3087
2024 Q4	$8.11K	Hold	1,327	–	–	﹤0.01%	2953
2024 Q3	$21.9K	Hold	1,327	–	–	﹤0.01%	2603
2024 Q2	$9.12K	Hold	1,327	–	–	﹤0.01%	2956
2024 Q1	$12.8K	Buy	1,327 +700	+112%	+$8.11K	﹤0.01%	2749
2023 Q4	$5.21K	Hold	627	–	–	﹤0.01%	2965
2023 Q3	$5.24K	Hold	627	–	–	﹤0.01%	2981
2023 Q2	$5.79K	Hold	627	–	–	﹤0.01%	3004
2023 Q1	$8.62K	Hold	627	–	–	﹤0.01%	2766
2022 Q4	$15.1K	Hold	627	–	–	﹤0.01%	2672
2022 Q3	$14K	Hold	627	–	–	﹤0.01%	2679
2022 Q2	$11K	Hold	627	–	–	﹤0.01%	2807
2022 Q1	$17K	Hold	627	–	–	﹤0.01%	2621
2021 Q4	$18K	Hold	627	–	–	﹤0.01%	2687
2021 Q3	$41K	Hold	627	–	–	﹤0.01%	2290
2021 Q2	$52K	Hold	627	–	–	﹤0.01%	2150
2021 Q1	$48K	Hold	627	–	–	﹤0.01%	2107
2020 Q4	$55K	Hold	627	–	–	﹤0.01%	1933
2020 Q3	$46K	Hold	627	–	–	﹤0.01%	1893
2020 Q2	$46K	Buy	627 +201	+47%	+$12.2K	﹤0.01%	1879
2020 Q1	$24K	Hold	426	–	–	﹤0.01%	2071
2019 Q4	$16K	Buy	+426	New	+$10.7K	﹤0.01%	2516

Other funds holding IGMS

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Ameritas Investment Partners's IGMS Position: Q2 2025 in Review

Ameritas Investment Partners sold out of IGM Biosciences (IGMS) in Q2 2025, closing a stake of 1,327 shares — an estimated $1.53K sold.

Ameritas Investment Partners first reported a position in IGMS in Q4 2019 and held it in 22 quarters. The position peaked at $55K in Q4 2020. 66 funds tracked by Wall St. Rank hold IGMS as of Q2 2025.

Ameritas Investment Partners reported no remaining IGM Biosciences position as of Q2 2025 after selling out during the quarter.
Ameritas Investment Partners sold 1,327 IGM Biosciences shares in Q2 2025, an estimated $1.53K.
Ameritas Investment Partners first reported a position in IGM Biosciences in Q4 2019 and held it in 22 quarters.
Ameritas Investment Partners's IGM Biosciences position peaked at $55K in Q4 2020.
66 funds tracked by Wall St. Rank held IGM Biosciences as of Q2 2025.

Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.